TherapeuticsMD, Inc.

US$1.74As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:TXMDHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (39.92%)
Div yield —
ROE (1.08%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.63
PE TTM —
TSR TTM 46.22%
Mkt cap US$20.14M
ROIC (7.31%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.22
27.43%
(61.52%)
Hold 1|3|12|8|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.03
0.02
0.03
0.03
17.83%
18.72%
18.11%
7.11%
Revenue$M
1.592
1.556
1.638
1.590
4.70%
0.03%
4.66%
(1.13%)
Peers (US$20.14M)
Cap (US$)
PE
26.95M
—
19.78M
2.549x
Capital
TTM
5Y
10Y
Leveragex
0.976
(2.271)
(1.818)
EBIT/Intx
1.977
0.450
0.478
Own earn%
(60.50)
149.33
146.61
Sh yield%
12.63
14.21
12.55
Owners
Insiders/Inst%
8.90
38.06
Short interest%
4.25
SBC / revenue%
2.35
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
12–16
$1 testx
—
Incr. ROIC%
6